Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 5, 1996, Pages 1251-1261

  Taylor, June S ^a,b   Langston, James W ^a,b   Reddick, Wilburn E ^a,c   Kingsley, Peter B ^a   Ogg, Robert J ^a,b   Pui, Margaret H ^a   Kun, Larry E ^a,b   Jenkins III, Jesse J ^a,b   Chen, Gang ^a   Ochs, Judith J ^a   Sanford, Robert A ^b   Heideman, Richard L ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c University of Memphis   (United States)

Author keywords

Astrocytomas; Brain neoplasms; Cerebral necrosis; Child; Delayed radiation necrosis; Human; Magnetic resonance spectroscopy

Indexed keywords

ADOLESCENT; ARTICLE; ASTROCYTOMA; BRAIN NECROSIS; BRAIN TUMOR; CANCER RISK; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RELIABILITY; STATISTICAL ANALYSIS; TUMOR RECURRENCE;

ADOLESCENT; BRAIN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NECROSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RADIOTHERAPY; SENSITIVITY AND SPECIFICITY;

EID: 18344413144     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00376-8     Document Type: Article

References (52)

1. 1. Alger, J. R.; Frank, J. A.; Bizzi, A.; Fulham, M. J.; DeSouza, B. X.; Duhaney, M. O.; Inscoe, S. W.; Black, J. L.; van Zijl, P. C.; Moonen, C. T.; Di Chiro, G. Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177:633-641; 1990.
2. 2. Arnold, D. L.; Shoubridge, E. A.; Villemure, J. G.; Feindel, W. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading. NMR Biomed. 3:184-189; 1990.
3. 3. Bruhn, H.; Michaelis, T.; Merboldt, K. D.; Hanicke, W.; Gyngell, M. L.; Hamburger, C.; Frahm, J. On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro. NMR Biomed. 5:253-258; 1992.
4. 4. Burger, P. C.; Vogel, F. S.; Green, S. B.; Strike, T. A. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106-1111; 1985.
5. 5. Carvalho, P. A.; Schwartz, R. B.; Alexander, E.; Garada, B. M.; Zimmerman, R. E.; Loeffler, J. S.; Holman, B. L. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J. Neurosurg. 77:565-570; 1992.
6. 31P magnetic resonance spectroscopy: Possible clinical significance. Mayo Clin. Proc. 63:1199-1207; 1988.
7. 7. Crist, W.; Kun, L. Common solid tumors of childhood. N. Engl. J. Med. 324:461-471; 1991.
8. 8. Daly, P. F.; Cohen, J. S. Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: A review. Cancer Res. 49:770-779; 1989.
9. 31P-NMR spectroscopy of human cancer cells proliferating in a basement membrane gel. FASEB J. 2:2596-2604; 1988.
10. 10. Day, M.; Vigneron, D.; Wald, L.; Huhn, S.; Hawkins, R.; Dillon, W.; Nelson, S. Comparison of 3D proton MR spectroscopy and FDG PET for assessment of brain tumor activity. Proceedings of the Society of Magnetic Resonance, 3rd Scientific Meeting, 1995:I-544 (Abstr.).
11. 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J. Comput. Assist. Tomogr. 15:67-76; 1991.
12. 12. Di Chiro, G.; Oldfield, E.; Wright, D. C.; De Michele, D.; Katz, D. A.; Patronas, N. J.; Doppman, J. L.; Larson, S. M.; Ito, M.; Kufta, C. V. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. AJR 150:189-197; 1988.
13. 13. Dooms, G. C.; Hecht, S.; Brant-Zawadzki, M.; Berthiaume, Y.; Norman, D.; Newton, T. H. Brain radiation lesions: MR imaging. Radiology 158:149-155; 1986.
14. 14. Duyn, J. H.; Gillen, J.; Sobering, G.; van Zijl, P. C.; Moonen, C. T. Multisection proton MR spectroscopic imaging of the brain. Radiology 188:277-282; 1993.
15. 15. Frahm, J.; Bruhn, H.; Gyngell, M. L.; Merboldt, K. D.; Hanicke, W.; Sauter, R. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn. Reson. Med. 11:47-63; 1989.
16. 16. Gill, S. S.; Thomas, D. G.; Van Bruggen, N.; Gadian, D. G.; Peden, C. J.; Bell, J. D.; Cox, I. J.; Menon, D. K.; Iles, R. A.; Bryant, D. J.; Coutts, G. A. Proton MR spectroscopy of intracranial tumours: In vivo and in vitro studies. J. Comput. Assist. Tomogr. 14:497-504; 1990.
17. 17. Groothuis, D. R.; Vick, N. A. Radionecrosis of the central nervous system: The perspective of the clinical neurologist and neuropathologist. In: Gilbert, H. A.; Kagan, A. R., eds. Radiation damage to the nervous system. New York: Raven Press; 1980:93-106.
18. 18. Gutin, P. H. Treatment of radiation necrosis of the brain. In: Gutin, P. H.; Leibel, S. A.; Sheline, G. E., eds. Radiation injury to the nervous system. New York: Raven Press, Ltd.; 1991:271-282.
19. 19. Gutin, P. H.; Leibel, S. A.; Wara, W. M.; Choucair, A.; Levin, V. A.; Philips, T. L.; Silver, P.; Da Silva, V.; Edwards, M. S.; Davis, R. L.; Weaver, K. A.; Lamb, S. Recurrent malignant gliomas: Survival following interstitial brachytherapy with high-activity iodine-125 sources. J. Neurosurg. 67:864-873; 1987.
20. 20. Hosmer, D.; Lemeshow, S. Applied logistical regression. New York: John Wiley & Sons; 1989:25.
21. 1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue. NMR Biomed. 7:149-155; 1994.
22. 22. Kim, E. E.; Chung, S. K.; Haynie, T. P.; Kim, C. G.; Cho, B. J.; Podoloff, D. A.; Tilbury, R. S.; Yang, D. J.; Yung, W. K.; Moser, R. P., Jr. Differentiation of residual or recurrent tumors from posttreatment changes with F-18 FDG PET. Radiographics 12:269-279; 1992.
23. 23. Kim, K. T.; Black, K. L.; Marciano, D.; Mazziotta, J. C.; Guze, B. H.; Grafton, S.; Hawkins, R. A.; Becker, D. P. Thallium-201 SPECT imaging of brain tumors: Methods and results. J. Nucl. Med. 31:965-969; 1990.
24. 24. Kleihues, P.; Burger, P. C.; Scheithauer, B. W. Histological typing of tumours of the central nervous system. Geneva: World Health Organization, Springer Verlag; 1993.
25. 25. Kreis, R.; Ernst, T.; Ross, B. D. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J. Magn. Reson. B 102:9-19; 1993.
26. 26. Larson, D. A.; Gutin, P. H.; Leibel, S. A.; Phillips, T. L.; Sneed, P. K.; Wara, W. M. Stereotaxic irradiation of brain tumors. Cancer 65:792-799; 1990.
27. 27. Leibel, S. A.; Gutin, P. H.; Davis, R. L. Factors affecting radiation injury after interstitial brachytherapy for brain tumors. In: Gutin, P. H.; Leibel, S. A.; Sheline, G. E., eds. Radiation injury to the nervous system. New York: Raven Press, Ltd.; 1991:257-270.
28. 28. Lilja, A.; Lundqvist, H.; Olsson, Y.; Spannare, B.; Gullberg, P.; Langstrom, B. Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions. Acta Radiol. 30:121-128; 1989.
29. 29. Lowry, O. H.; Berger, S. J.; Chi, M. M.-Y.; Carter, J. G.; Blackshaw, A.; Outlaw, W. Diversity of metabolic patterns in human brain tumors. I. High energy phosphate compounds and basic composition. J. Neurochem. 29:959-977; 1977.
30. 30. Luyten, P. R.; Marien, A. J. H.; Heindel, W.; van Gerwen, P. H. J.; Herholz, K.; den Hollander, J. A.; Friedmann, G.; Heiss, W. D. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 176:791-799; 1990.
31. 31. Metz, C. E. Some practical issues of experimental design and data analysis in radiological ROC studies. Invest. Radiol. 24:234-245; 1989.
32. 32. Michaelis, T.; Merboldt, K. D.; Bruhn, H.; Hanicke, W.; Frahm, J. Absolute concentrations of metabolites in the adult human brain in vivo: Quantification of localized proton MR spectra. Radiology 187:219-227; 1993.
33. 33. Negendank, W. Studies of human tumors by MRS: A review. NMR Biomed. 5:303-324; 1992.
34. 34. Ogawa, T.; Kanno, I.; Shishido, F.; Inugami, A.; Higano, H.; Fujita, H.; Murakami, M.; Uemura, K.; Yasui, N.; Mineura, K. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol. 32:197-202; 1991.
35. 35. Ogawa, T.; Uemura, K.; Kanno, I.; Shishido, F.; Inugami, T.; Yamaguchi, T.; Murakami, M.; Hirata, K.; Kato, T.; Mineura, K. Delayed radiation necrosis of brain evaluated positron emission tomography. Tohoku. J. Exp. Med. 155:247-260; 1988.
36. 1H NMR spectroscopy. J. Magn. Reson. Ser. B 104:1-10; 1994.
37. 37. Ott, D.; Hennig, J.; Ernst, T. Human brain tumors: Assessment with in vivo proton MR spectroscopy. Radiology 186:745-752; 1993.
38. 38. Sauter, R. Clinical MR spectroscopy of the brain - A volunteer baseline study. Proceedings of Conference on Advances in proton MRS of the Brain, Dec. 16-18, 1992, Oxford, GB, 1992. (Abstr.)
39. 39. Scharfen, C. O.; Sneed, P. K.; Wara, W. M.; Larson, D. A.; Phillips, T. L.; Prados, M. D.; Weaver, K. A.; Malec, M.; Acord, P.; Lamborn, K. R.; Lamb, S. A.; Ham, B.; Gutin, P. H. High activity iodine-125 interstitial implant for gliomas. Int. J. Radiat. Oncol. Biol. Phys 24:583-591; 1992.
40. 31P MR spectra measured on volunteers and on intracranial tumor patients. Magn. Reson. Med. 11:349-366; 1989.
41. 41. Shrieve, D. C.; Alexander, E.; Wen, P. Y.; Fine, H. A.; Kooy, H. M.; Black, P. M.; Loeffler, J. S. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36:275-282; 1995.
42. 42. Sutton, L. N.; Wang, Z.; Gusnard, D.; Lange, B.; Perilongo, G.; Bogdan, A. R.; Detre, J. A.; Rorke, L.; Zimmerman, R. A. Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 31:195-202; 1992.
43. 1H magnetic resonance spectroscopy of pediatric posterior fossa tumors in vitro. J. Neurosurg. 81:443-448; 1994.
44. 44. Valk, P. E.; Budurger, T. F.; Levin, V. A.; Silver, P.; Gutin, P. H.; Doyle, W. K. PET of malignant cerebral tumors after interstitial brachytherapy. J. Neurosurg. 69:830-838; 1988.
45. 45. Valk, P. E.; Dillon, W. P. Diagnostic imaging of central nervous system radiation injury. In: Gutin, P. H.; Leibel, S. A.; Sheline, G. E., eds. Radiation injury to the nervous system. New York: Raven Press, Ltd.; 1991:211-237.
46. 46. van Dellen, J. R.; Danziger, A. Failure of computerized tomography to differentiate between radiation necrosis and cerebral tumor. S. Afr. Med. J. 53:171-172; 1978.
47. 47. Vining, D. J.; Gladish, G. W. Receiver operating characteristic curves: A basic understanding. Radiographics 12:1147-1154; 1992.
48. 48. Wang, Z.; Sutton, L. N.; Cnaan, A.; Haselgrove, J. C.; Rorke, L. B.; Zhao, H.; Bilaniuk, L. T.; Zimmerman, R. A. Proton magnetic resonance spectroscopy of pediatric cerebellar tumors. Am. J. Neuroradiol. 16:1821-1833; 1995.
49. 49. Webb, P. G.; Sailasuta, N.; Kohler, S. J.; Raidy, T.; Moats, R. A.; Hurd, R. E. Automated single-voxel proton MRS: Technical development and multisite verification. Magn. Reson. Med. 31:365-373; 1994.
50. 50. Wen, P. Y.; Alexander, E.; Black, P. M.; Fine, H. A.; Riese, N.; Levin, J. M.; Coleman, C. N.; Loeffler, J. S. Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas. Cancer 73:3029-3036; 1994.
51. 51. Yoshii, Y.; Komatsu, Y.; Yamada, T.; Hyodo, A.; Nose, T.; Kobayashi, E. Malignancy and viability of intraparenchymal brain tumours: Correlation between Gd-DTPA contrast MR images and proliferative potentials. Acta Neurochir. (Wien) 117:187-194; 1992.
52. 52. Yousem, D. M.; Lenkinski, R. E.; Evans, S.; Allen, D.; O'Brien, R.; Curran, W.; Schnall, M.; Bennett, M.; Wehrli, S.; Grossman, R. Proton MR spectroscopy of experimental radiation-induced white matter injury. J. Comput. Assist. Tomogr. 16:543-548; 1992.